Definitive Healthcare Corp. is a provider of healthcare data and analytics that delivers commercial intelligence through a software-as-a-service platform. The company aggregates data on healthcare organizations, providers, services, medical and scientific experts, claims, and consumers to support product development, go-to-market planning, and sales and marketing execution. Its primary end markets include Life Sciences, comprising biopharmaceutical and medical device companies; Provider, consisting of hospitals, health systems, and care delivery organizations; and Diversified, which includes healthcare information technology firms, staffing agencies, commercial real estate firms, financial institutions, and marketing agencies. The company offers detailed data on health systems, hospitals, physicians, physician groups, surgery centers, imaging centers, long-term care facilities, and clinics, along with all-payor medical and prescription claims data and insights into key opinion leaders. Definitive Healthcare also provides strategic services through data scientists and consultants to help clients integrate insights into workflows, as well as activation services for digital advertising campaigns using HIPAA-compliant consumer data. Founded in 2011, the company was incorporated as Definitive Healthcare Corp. in May 2021 to facilitate its initial public offering. It serves customers in the U.S., Europe, and India, with a workforce distributed across these regions.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Health Information Services Homepage definitivehc.com
Sector Healthcare IR page definitivehc.com
Tags
healthcare data, analytics, claims data, consumer insights, provider intelligence, life sciences, digital marketing activation, saas, key opinion leaders, health systems
Press page definitivehc.com/about/press

Metrics

Valuation  
Market cap $ 96.983M
Market cap (USD) $ 96.983M
P/E -0.58
PEG —
P/BV 0.51
P/S 0.43
P/OCF 2.61
P/FCF 4.01
Dividend yield 1.1%
Turnover / mcap —
Returns  
ROE -28.2%
ROI -25.5%
ROIC -30.9%
Profit margin -57.5%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 84.1%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 12
Quality score -22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 241.521M 252.202M 251.415M 222.653M 166.154M 118.317M
Net profit -138.932M -413.124M -202.388M -6.037M -17.677M -51.157M
Free cash flow 37.057M 45.852M 38.213M 27.253M 18.481M 21.822M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 2.87 4.11 9.94 10.99 27.33 —
Price performance 12m -0.3 -0.59 -0.1 -0.6 — —

Filed figures

Figure Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 33.1M 43.3M 58.8M 59.2M 53.2M 52M
↳ YoY growth +30.9% +35.7% +0.8% -10.2% -2.4%
↳ 5y CAGR +9.4%
Borrowings, current (USD) — — 4.68M 6.88M 8.59M 13.8M 13.8M 8.75M
Borrowings, non-current (USD) — — 457M 264M 256M 243M 229M 156M
Lease liabilities (USD) — — — 0.00 11.5M 11.6M 9.99M 7.83M
Cash and deposits (USD) 19.4M 8.62M 24.8M 387M 147M 131M 105M 164M
Intangible assets (USD) — — 410M 352M 351M 323M 298M 247M
Right-of-use assets (USD) — — — 0.00 9.68M 9.59M 7.52M 5.39M
Net debt (borrowings + leases - cash) (USD) — — 437M -117M 129M 137M 148M 9.04M
Cash flow detail
Operating cash flow (USD) — — 23.2M 25.2M 35.6M 41.2M 58.2M 53.8M
Purchases of property, plant and equipment (USD) — — -1.4M -6.73M -8.33M -2.98M -12.3M -16.7M
Change in receivables (cash effect) (USD) — — -8.29M -10.7M -13.2M 811,000 5.69M 1.38M
Change in payables (cash effect) (USD) — — 3M 1.09M 358,000 1.33M -5.46M -1.09M
Share buybacks (cash effect) (USD) — — — — 0.00 0.00 -22.4M -49.5M
Interest paid (cash effect) (USD) — — -26M -29.6M -10.4M -14.5M -14.2M -10.8M
Income taxes paid (cash effect) (USD) — — 0.00 -13,000 0.00 -136,000 0.00 -833,000
Share-based compensation (USD) — — 1.75M 9.96M 36.4M 48.7M 38.1M 29.1M
Operating cash flow before change in receivables (USD) — — 31.5M 35.9M 48.8M 40.4M 52.5M 52.4M
Free cash flow (OCF - PPE - intangibles) (USD) — — 21.8M 18.5M 27.3M 38.2M 45.9M 37.1M
Income detail
Research and development expense (USD) — — 11.1M 18.6M 34.9M 42.4M 36.5M 34.8M
↳ 5y CAGR +25.7%
Total comprehensive income (USD) — — -131,000 -17.6M -2.43M -204M -416M -140M
Comprehensive income to owners (USD) — — -131,000 -17.6M -2.43M -204M -416M -140M
Provision for credit losses (USD) — — — — 1.33M 1.37M 947,000 -232,000
Credit cost ratio (credit losses / average receivables) (%) — — — — 2.6% 2.3% 1.7% 0.4%
Reported Mar 15, 2022 Nov 8, 2021 Mar 15, 2022 May 5, 2022 Feb 27, 2025 Feb 27, 2025 Feb 26, 2026 Feb 26, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Third Quarter Revenue Within Guidance Range; Profit Surpasses Expectations

Framingham, MA (November 5, 2026) – Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended September 30, 2026.

Third Quarter 2026 Financial Highlights:

•Revenue was $54.7 million, a decrease of 9% from $60.0 million in Q3 2025.

•Net Loss was $(5.4) million, or (10)% of revenue, compared to $(17.8) million, or (30)% of revenue in Q3 2025.

•Adjusted Net Income was $8.8 million, compared to $9.7 million in Q3 2025.

•Adjusted EBITDA was $15.7 million, or 29% of revenue, compared to $18.9 million, or 32% of revenue in Q3 2025.

•Cash Flow from Operations was $11.4 million in the quarter.

•Unlevered Free Cash Flow was $13.0 million in the quarter.

“Since joining Definitive, I’ve been focused on listening to our customers and our employees,” said Clay Ritchey, CEO of Definitive Healthcare. “What I’ve heard confirms my belief in the strength of our position in the market, and it has also shown me where we can execute better.

Share this post

Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety

Framingham, MA – October 1, 2026 – Definitive Healthcare

(Nasdaq: DH), a provider of healthcare data and analytics, today announced that it has joined the Network Advertising Initiative (NAI). Membership in the NAI underscores Definitive Healthcare’s commitment to responsible data stewardship and rigorous privacy standards for sensitive healthcare data. Definitive Healthcare now provides its advertising customers with added assurance of its commitment to compliance with federal and state data protection requirements.

“Privacy is paramount when it comes to health data. Joining the NAI reconfirms that Definitive Healthcare, above all else, works to protect this type of data every single day,” said Sally Slarke, Senior Vice President of Commercial and Digital at Definitive Healthcare. “The stakes are high for companies looking to connect the right healthcare services with the right audiences. Even unintentional missteps or small compliance gaps can expose organizations to fines or significant legal risk. Acceptance into the NAI reinforces what we at Definitive Healthcare have known for years: our commercial healthcare data privacy standards adhere to the highest in the industry.”

Federal regulations as well as some state privacy laws protect individuals by shielding identifiable healthcare data from uses outside of healthcare-specific activities. Digital advertisers must navigate these privacy laws while still reaching highly valued audiences, such as healthcare consumers and providers. Definitive Healthcare’s membership in the NAI helps ensure its customers, including providers, pharmaceutical companies, and healthcare advertising agencies, that the data they maintain is at the highest level of privacy throughout the industry.

“Companies managing commercial healthcare data face a complex and continually evolving patchwork of legal and regulatory challenges. Definitive Healthcare’s NAI membership reflects its dedication to responsibly handle this data while prioritizing privacy,” said David LeDuc, Vice President of Public Policy at the NAI. “We look forward to collaborating with Definitive Healthcare to help guide their policies and data governance as it relates to consumer data used for health-related advertising, continually seeking to balance the beneficial outcomes of digital health advertising, while minimizing privacy risks.”

“We’re thrilled to join the NAI, further reinforcing our commitment to responsible data stewardship,” said Don Lee, Head of Digital Sales at Definitive Healthcare. “I’m especially excited to bring this additional layer of reassurance to customers who rely on our consumer data and solutions like Digital Audiences to fulfill the critical mission of connecting the right care with the right people in a compliant and responsible way.”

As a member of the NAI, Definitive Healthcare will be able to join industry leaders in supporting healthcare data safety. Earlier this year, NAI unveiled a framework

to help businesses easily identify what is or isn’t sensitive healthcare data.

As previously disclosed, Definitive Healthcare Corp. (the “Company”) is party to a tax receivable agreement, dated as of September 14, 2021 (the “TRA”), with AIDH TopCo, LLC, certain affiliates of Advent International, L.P. (collectively, “Advent”), certain affiliates of Spectrum Equity Management, L.P. (collectively, “Spectrum Equity”), certain affiliates of 22C Capital LLC (collectively, “22C Capital”), Jason Krantz (“Mr. Krantz”), and certain other parties thereto (together with Advent, Spectrum Equity, 22C Capital, and Mr. Krantz, the “TRA Holders”). The Company is voluntarily disclosing that representatives of the TRA Holders, acting on behalf of the applicable TRA Holders, have irrevocably waived, pursuant to written agreements between the TRA Holders, the right of such TRA Holders to receive an Early Termination Payment (as defined in the TRA) pursuant to Section 4.1(c) of the TRA in connection with any Change of Control (as defined in the TRA) for which the definitive merger agreement is executed on or prior to December 31, 2026 (a “Qualifying Change of Control”) and, upon the consummation of a Qualifying Change of Control, the TRA will terminate in accordance with its term

Prompts

Definitive Healthcare Corp. (ticker DH), listed in United States.

ETFs Holding Definitive Healthcare Corp.

ETF Weight in ETF Shares Market value As of
DFAS 0.00% 617,928 $ 772.41K Nov 12, 2026
DFAC 0.00% 204,300 $ 255.375K Nov 12, 2026
DFSU 0.00% 3,600 $ 4,500.00 Nov 12, 2026